Company Filing History:
Years Active: 2021
Title: Innovations by Tae-ho Jang: A Pioneer in Pyrrolo-Pyrimidine Derivative Compounds
Introduction
Tae-ho Jang is a renowned inventor based in Gyeongsangbuk-do, South Korea. With a focus on pharmaceutical innovations, he has made significant contributions to the field of medicinal chemistry. His work has inspired many in the research community, particularly in combating protein kinase-related diseases.
Latest Patents
Tae-ho Jang holds a patent for a novel pyrrolo-pyrimidine derivative compound, which presents a new preparation method and a pharmaceutical composition. This invention is designed to be used as an effective ingredient for the prevention or treatment of protein kinase-related diseases. Notably, the compound demonstrates remarkable inhibitory activity against LRRK2 kinase, making it effective in specific cell lines associated with brain tumors. This innovation opens new avenues for research and therapeutic applications in treating various protein kinase-related diseases.
Career Highlights
Jang's career has been marked by his involvement with prestigious organizations. He has worked with the Daegu-Gyeongbuk Medical Innovation Foundation and the National Cancer Center, where he has contributed to groundbreaking research in cancer treatment. His focus on innovation has enabled the development of effective medicinal compounds that address critical health challenges.
Collaborations
Throughout his career, Tae-ho Jang has collaborated with notable colleagues, including Hwan Geun Choi and Jong Bae Park. These partnerships have proven invaluable in advancing his research and maximizing the impact of his patents in the medical community.
Conclusion
Tae-ho Jang is an exemplary inventor whose work in pyrrolo-pyrimidine derivative compounds is poised to make a lasting impact on the treatment of protein kinase-related diseases. Through his innovative approaches and collaborative spirit, he continues to push the boundaries of medicinal chemistry, offering hope for effective therapies in the fight against cancer and other related illnesses.